⌘K
Loading ticker…
As of 2026-08-21, Lisata Therapeutics, Inc. Common Stock (LSTA) has a 3-month relative strength percentile of 6 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 34. The current market Stance is 49.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 14.7%, relative volume 66.93×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
LSTA is in a stage 3 topping pattern, week 9. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -35.9% / -50.8%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
LSTA is held by 2 ETFs as of Apr 2026. Top owner: DFSU at 0.00% weight, $312 notional.
Held by 4 ETFs · $1M across latest filings · largest weight 0.00% (VXF).
Top 2 by value, from SEC N-PORT-P filings dated Apr 2026.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | LSTA Jan avg: 41.20% median: 15.99% win: 50% σ: 76.29% n: 4 2022-09-16 → 2026-07-31 | LSTA Feb avg: -2.34% median: -8.13% win: 25% σ: 14.34% n: 4 2022-09-16 → 2026-07-31 | LSTA Mar avg: 7.53% median: 4.59% win: 75% σ: 10.28% n: 4 2022-09-16 → 2026-07-31 | LSTA Apr avg: -12.31% median: -6.17% win: 50% σ: 18.02% n: 4 2022-09-16 → 2026-07-31 | LSTA May avg: 12.04% median: 8.92% win: 100% σ: 9.72% n: 4 2022-09-16 → 2026-07-31 | LSTA Jun avg: 5.99% median: 7.84% win: 75% σ: 11.84% n: 4 2022-09-16 → 2026-07-31 | LSTA Jul avg: -26.75% median: -14.39% win: 0% σ: 29.61% n: 4 2022-09-16 → 2026-07-31 | LSTA Aug avg: -16.46% median: -11.68% win: 0% σ: 13.06% n: 3 2022-09-16 → 2026-07-31 (current) | LSTA Sep avg: -2.30% median: 1.90% win: 50% σ: 16.86% n: 4 2022-09-16 → 2026-07-31 | LSTA Oct avg: -1.55% median: -2.13% win: 50% σ: 6.77% n: 4 2022-09-16 → 2026-07-31 | LSTA Nov avg: -11.29% median: -9.96% win: 25% σ: 12.73% n: 4 2022-09-16 → 2026-07-31 | LSTA Dec avg: -1.20% median: -0.87% win: 50% σ: 22.57% n: 4 2022-09-16 → 2026-07-31 |